256 related articles for article (PubMed ID: 23581392)
1. Could pramipexole induce acute mania? A case report.
Bet PM; Franken LG; Klumpers UM
Bipolar Disord; 2013 Jun; 15(4):446-8. PubMed ID: 23581392
[TBL] [Abstract][Full Text] [Related]
2. Pramipexole in the treatment of restless legs syndrome: a follow-up study.
Montplaisir J; Denesle R; Petit D
Eur J Neurol; 2000 May; 7 Suppl 1():27-31. PubMed ID: 11054156
[TBL] [Abstract][Full Text] [Related]
3. A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.
Jama L; Hirvonen K; Partinen M; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
Sleep Med; 2009 Jun; 10(6):630-6. PubMed ID: 19171500
[TBL] [Abstract][Full Text] [Related]
4. First night efficacy of pramipexole in restless legs syndrome and periodic leg movements.
Manconi M; Ferri R; Zucconi M; Oldani A; Fantini ML; Castronovo V; Ferini-Strambi L
Sleep Med; 2007 Aug; 8(5):491-7. PubMed ID: 17512780
[TBL] [Abstract][Full Text] [Related]
5. Assessing efficacy/effectiveness and safety/tolerability profiles of adjunctive pramipexole in bipolar depression: acute versus long-term data.
Dell'Osso B; Ketter TA
Int Clin Psychopharmacol; 2013 Nov; 28(6):297-304. PubMed ID: 24081199
[TBL] [Abstract][Full Text] [Related]
6. The acute effect of a low dosage of pramipexole on severe idiopathic restless legs syndrome: an open-label trial.
Merlino G; Dolso P; Canesin R; Cancelli I; Valente M; Gigli GL
Neuropsychobiology; 2006; 54(3):195-200. PubMed ID: 17314491
[TBL] [Abstract][Full Text] [Related]
7. Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study.
Vieta E; Panicali F; Goetz I; Reed C; Comes M; Tohen M;
J Affect Disord; 2008 Feb; 106(1-2):63-72. PubMed ID: 17582508
[TBL] [Abstract][Full Text] [Related]
8. Preferential D2 or preferential D3 dopamine agonists in restless legs syndrome.
Manconi M; Ferri R; Zucconi M; Clemens S; Giarolli L; Bottasini V; Ferini-Strambi L
Neurology; 2011 Jul; 77(2):110-7. PubMed ID: 21715702
[TBL] [Abstract][Full Text] [Related]
9. [The role of low-dose pramipexole in the treatment of treatment-resistant bipolar depression: a case report].
Akdeniz F; Aldemir E; Vahip S
Turk Psikiyatri Derg; 2009; 20(1):94-8. PubMed ID: 19306131
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience with pramipexole in the treatment of restless legs syndrome.
Merlino G; Serafini A; Robiony F; Valente M; Gigli GL
Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):225-35. PubMed ID: 18248314
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study--the PRELUDE study.
Partinen M; Hirvonen K; Jama L; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
Sleep Med; 2006 Aug; 7(5):407-17. PubMed ID: 16815748
[TBL] [Abstract][Full Text] [Related]
12. Effect of pramipexole in treatment of resistant restless legs syndrome.
Lin SC; Kaplan J; Burger CD; Fredrickson PA
Mayo Clin Proc; 1998 Jun; 73(6):497-500. PubMed ID: 9621854
[TBL] [Abstract][Full Text] [Related]
13. Open-label study of the long-term efficacy and safety of pramipexole in patients with Restless Legs Syndrome (extension of the PRELUDE study).
Partinen M; Hirvonen K; Jama L; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
Sleep Med; 2008 Jul; 9(5):537-41. PubMed ID: 18276187
[TBL] [Abstract][Full Text] [Related]
14. Recurrence of cluster headache with pramipexole.
Ossemann M
Acta Neurol Belg; 2010 Sep; 110(3):279-80. PubMed ID: 21114140
[TBL] [Abstract][Full Text] [Related]
15. Factors affecting the efficacy of pramipexole in patients with restless legs syndrome.
Rezvani M; Zamani B; Fereshtehnejad SM
Acta Med Iran; 2013 Jul; 51(6):377-85. PubMed ID: 23852842
[TBL] [Abstract][Full Text] [Related]
16. Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction.
Burdick KE; Braga RJ; Nnadi CU; Shaya Y; Stearns WH; Malhotra AK
J Clin Psychiatry; 2012 Jan; 73(1):103-12. PubMed ID: 22152405
[TBL] [Abstract][Full Text] [Related]
17. Pramipexole (Mirapex) for restless legs syndrome.
Med Lett Drugs Ther; 2007 Mar; 49(1257):26-8. PubMed ID: 17375031
[No Abstract] [Full Text] [Related]
18. Pramipexole in psychiatry: a systematic review of the literature.
Aiken CB
J Clin Psychiatry; 2007 Aug; 68(8):1230-6. PubMed ID: 17854248
[TBL] [Abstract][Full Text] [Related]
19. Pramipexole induced psychosis in a patient with restless legs syndrome.
Signorelli MS; Battaglia E; Costanzo MC; Cannavò D
BMJ Case Rep; 2013 Sep; 2013():. PubMed ID: 24049088
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of pramipexole for patients with restless legs syndrome (RLS) and RLS-related impairment of mood.
Montagna P; Hornyak M; Ulfberg J; Hong SB; Koester J; Crespi G; Albrecht S
Sleep Med; 2011 Jan; 12(1):34-40. PubMed ID: 20965780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
